DoD Tuberous Sclerosis Complex Exploration Hypothesis Development Award | Apply Online

Opportunity Summary:

The DoD Tuberous Sclerosis Complex Exploration Hypothesis Development Award is a U.S. Department of Defense research funding opportunity managed through the Tuberous Sclerosis Complex Research Program (TSCRP) under the U.S. Army Medical Research Acquisition Activity. Its overall mission is to push forward innovative research that clarifies how tuberous sclerosis complex (TSC) develops and presents across the body, with the practical goal of improving outcomes and quality of life for people living with TSC. The award mechanism is meant to help investigators test early-stage, unconventional ideas that could open up new directions in the field, especially where a bold concept needs initial proof-of-principle data before it can mature into a fully developed hypothesis and a larger research program.

A central feature of this award is its emphasis on high-risk, high-reward science. The program is explicitly designed to support exploratory work, including projects sparked by unexpected or serendipitous observations, where the key value is the potential to uncover something genuinely new rather than to extend incremental advances. Applicants are encouraged to include preliminary or published data when available, but this is not a requirement, which signals that the funding is aimed at enabling early exploration rather than rewarding only well-established lines of work. In practice, the expectation is that studies funded through this mechanism will generate enough initial evidence, feasibility results, or conceptual grounding to justify a new hypothesis and set the stage for more extensive follow-on research.

The FY13 TSCRP focus areas outline the kinds of scientific and clinical problems the program most wants to see addressed. These include research on genetic, epigenetic, and non-genetic modifiers that influence TSC severity and variability, recognizing that people with the same core diagnosis can experience very different disease courses. The program also invites work on preclinical models and therapeutic strategies, including approaches such as cytotoxic agents or combination therapies, which reflects interest in moving beyond single-agent treatments and toward strategies that may target multiple disease mechanisms. Another major priority is biomarker development for early detection, prognosis, and prediction of treatment response, spanning modalities like blood-based markers, imaging, electrophysiology, prenatal testing, and pharmacogenetics. This focus highlights the need for tools that can guide earlier diagnosis, stratify risk, and personalize treatment decisions.

The opportunity also points to specific interest in adult manifestations of TSC, including topics such as adult care management, age-specific pathogenesis, epidemiology, renal and reproductive issues, and lymphangioleiomyomatosis (LAM). This emphasis reflects an understanding that TSC is a lifelong condition and that adult complications can differ in important ways from pediatric presentations. In addition, the TSCRP encourages projects that examine the long-term benefits and effects of mTOR inhibitors and other agents, an area tied to real-world questions about durability of response, side effects, optimal treatment duration, and long-term disease modification. The program further prioritizes novel strategies for diagnosis, treatment, and prevention of TSC manifestations, particularly approaches aimed at early identification and early intervention, consistent with the idea that earlier action could reduce downstream neurological and systemic complications.

On the mechanistic side, the focus areas include cellular and molecular mechanisms of TSC and LAM pathogenesis, reinforcing the program's interest in fundamental biology that can translate into therapeutic targets. Neurological complications are also strongly represented: the causes and treatment of epilepsy in TSC are called out directly, as are the causes and treatment of TSC-associated neurocognitive disorders, including cognitive impairment and psychiatric, behavioral, and sleep disorders. Collectively, these topics signal that the program is seeking proposals that connect underlying mechanisms to clinical impact, and that address both the medical and neurodevelopmental burdens that often shape daily life for individuals and families affected by TSC.

From an administrative standpoint, this opportunity was posted May 3, 2013, with a closing date of July 11, 2013, and it was later archived on August 10, 2013. The funding opportunity number is W81XWH-13-TSCRP-EHDA, and it supports awards through either a grant or cooperative agreement mechanism under the Department of Defense research and development umbrella. The program anticipated making about four awards with an estimated total funding level of $640,000, and it did not require cost sharing or matching funds. Eligibility was described as unrestricted, meaning a wide range of organizations could apply, subject to any additional eligibility notes in the full announcement. For help accessing the announcement or navigating submission issues, applicants were directed to the CDMRP Help Desk (help@cdmrp.org, 301-682-5507), reflecting that the program is administered within the Congressionally Directed Medical Research Programs infrastructure.

Browse more opportunities from the same agency: Dept. of the Army USAMRAA

Browse more opportunities from the same category: Science and Technology and other Research and Development

Next opportunity: DoD Tuberous Sclerosis Complex Idea Development Award

Previous opportunity: Short Courses on Innovative Methodologies in the Behavioral and Social Sciences (R25)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for W81XWH 13 TSCRP EHDA

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (W81XWH 13 TSCRP EHDA) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 13 TSCRP EHDA", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.